Literature DB >> 7711927

Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo.

R Vejsada1, Y Sagot, A C Kato.   

Abstract

A reproducible neuronal degeneration induced by nerve lesion in neonatal rats or mice provides a convenient in vivo assay for testing the survival-promoting activity of putative growth factors on motoneurons. The goal of this study was to compare the rescue effects of the four known neurotrophins [nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4 (NT-4)] and two of the cytokines [ciliary neurotrophic factor (CNTF) and leukaemia inhibitory factor (LIF)] in one particular experimental model of spinal motoneuron degeneration at two different survival times. The sciatic nerve was cut in neonatal rats and the factors were applied onto the nerve stump; bovine serum albumin was used in controls. Simultaneous application of the retrograde tracer fluoro-gold made it possible to count motoneurons specifically in the sciatic pool. One week after lesion, the neurotrophins BDNF, NT-3 and NT-4, but not NGF, equally enhanced motoneuron survival compared to controls; their effects were significantly better than those of the cytokines. However, the rescue from cell death was only transitory because a great number of the motoneurons died during the second week after nerve lesion. Additional BDNF and/or CNTF supplied by repeated subcutaneous injections (1 mg/ml) over 2 weeks could not prevent this delayed motoneuron loss. These results suggest that still other factors or alternative routes of administration may be required for permanent rescue of the lesioned immature motoneurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711927     DOI: 10.1111/j.1460-9568.1995.tb01025.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

1.  Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration.

Authors:  K Namikawa; M Honma; K Abe; M Takeda; K Mansur; T Obata; A Miwa; H Okado; H Kiyama
Journal:  J Neurosci       Date:  2000-04-15       Impact factor: 6.167

Review 2.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 3.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

4.  Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.

Authors:  K D Anderson; N Panayotatos; T L Corcoran; R M Lindsay; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 5.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

6.  Survival and regeneration of cutaneous and muscular afferent neurons after peripheral nerve injury in adult rats.

Authors:  Dag Welin; Liudmila N Novikova; Mikael Wiberg; Jan-Olof Kellerth; Lev N Novikov
Journal:  Exp Brain Res       Date:  2007-12-05       Impact factor: 1.972

Review 7.  Amyotrophic lateral sclerosis: current and future treatment strategies.

Authors:  B W Festoff
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

8.  Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease.

Authors:  Y Sagot; T Rossé; R Vejsada; D Perrelet; A C Kato
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

Review 9.  The cellular and molecular basis of peripheral nerve regeneration.

Authors:  S Y Fu; T Gordon
Journal:  Mol Neurobiol       Date:  1997 Feb-Apr       Impact factor: 5.590

Review 10.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.